189 related articles for article (PubMed ID: 37743418)
1. Non-small cell lung cancers (NSCLCs) oncolysis using coxsackievirus B5 and synergistic DNA-damage response inhibitors.
Cui B; Song L; Wang Q; Li K; He Q; Wu X; Gao F; Liu M; An C; Gao Q; Hu C; Hao X; Dong F; Zhou J; Liu D; Song Z; Yan X; Zhang J; Bai Y; Mao Q; Yang X; Liang Z
Signal Transduct Target Ther; 2023 Sep; 8(1):366. PubMed ID: 37743418
[TBL] [Abstract][Full Text] [Related]
2. Synergistic anti-tumor efficacy of oncolytic influenza viruses and B7-H3 immune- checkpoint inhibitors against IC-resistant lung cancers.
Masemann D; Meissner R; Schied T; Lichty BD; Rapp UR; Wixler V; Ludwig S
Oncoimmunology; 2021 Feb; 10(1):1885778. PubMed ID: 33643696
[TBL] [Abstract][Full Text] [Related]
3. Enhanced therapeutic efficacy of oncolytic herpes vector G207 against human non-small cell lung cancer--expression of an RNA-binding protein, Musashi1, as a marker for the tailored gene therapy.
Kanai R; Eguchi K; Takahashi M; Goldman S; Okano H; Kawase T; Yazaki T
J Gene Med; 2006 Nov; 8(11):1329-40. PubMed ID: 16955534
[TBL] [Abstract][Full Text] [Related]
4. [Synergistic Effect of NF-κB Signaling Pathway Inhibitor and Oncolytic
Measles Virus Vaccine Strain against Lung Cancer and Underlying Mechanisms].
Xia M; Meng G; Dong J
Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):245-253. PubMed ID: 33775041
[TBL] [Abstract][Full Text] [Related]
5. ATM-mediated DNA double-strand break response facilitated oncolytic Newcastle disease virus replication and promoted syncytium formation in tumor cells.
Ren S; Ur Rehman Z; Gao B; Yang Z; Zhou J; Meng C; Song C; Nair V; Sun Y; Ding C
PLoS Pathog; 2020 Jun; 16(6):e1008514. PubMed ID: 32479542
[TBL] [Abstract][Full Text] [Related]
6. [Oncolytic enteroviruses].
Chumakov PM; Morozova VV; Babkin IV; Baĭkov IK; Netesov SV; Tikunova NV
Mol Biol (Mosk); 2012; 46(5):712-25. PubMed ID: 23156670
[TBL] [Abstract][Full Text] [Related]
7. Coxsackievirus A11 is an immunostimulatory oncolytic virus that induces complete tumor regression in a human non-small cell lung cancer.
Sakamoto A; Inoue H; Miyamoto S; Ito S; Soda Y; Tani K
Sci Rep; 2023 Apr; 13(1):5924. PubMed ID: 37046036
[TBL] [Abstract][Full Text] [Related]
8. E1A, E1B double-restricted adenovirus with RGD-fiber modification exhibits enhanced oncolysis for CAR-deficient biliary cancers.
Wakayama M; Abei M; Kawashima R; Seo E; Fukuda K; Ugai H; Murata T; Tanaka N; Hyodo I; Hamada H; Yokoyama KK
Clin Cancer Res; 2007 May; 13(10):3043-50. PubMed ID: 17505007
[TBL] [Abstract][Full Text] [Related]
9. Mitophagy switches cell death from apoptosis to necrosis in NSCLC cells treated with oncolytic measles virus.
Xia M; Meng G; Jiang A; Chen A; Dahlhaus M; Gonzalez P; Beltinger C; Wei J
Oncotarget; 2014 Jun; 5(11):3907-18. PubMed ID: 25004098
[TBL] [Abstract][Full Text] [Related]
10. Oncolytic activity of a coxsackievirus B3 strain in human endometrial cancer cell lines.
Lin Y; Wang W; Wan J; Yang Y; Fu W; Pan D; Cai L; Cheng T; Huang X; Wang Y
Virol J; 2018 Apr; 15(1):65. PubMed ID: 29631630
[TBL] [Abstract][Full Text] [Related]
11. Coxsackievirus B3 is an oncolytic virus with immunostimulatory properties that is active against lung adenocarcinoma.
Miyamoto S; Inoue H; Nakamura T; Yamada M; Sakamoto C; Urata Y; Okazaki T; Marumoto T; Takahashi A; Takayama K; Nakanishi Y; Shimizu H; Tani K
Cancer Res; 2012 May; 72(10):2609-21. PubMed ID: 22461509
[TBL] [Abstract][Full Text] [Related]
12. PolySia-Specific Retargeting of Oncolytic Viruses Triggers Tumor-Specific Immune Responses and Facilitates Therapy of Disseminated Lung Cancer.
Kloos A; Woller N; Gürlevik E; Ureche CI; Niemann J; Armbrecht N; Martin NT; Geffers R; Manns MP; Gerardy-Schahn R; Kühnel F
Cancer Immunol Res; 2015 Jul; 3(7):751-63. PubMed ID: 25701327
[TBL] [Abstract][Full Text] [Related]
13. Genomic DNA damage and ATR-Chk1 signaling determine oncolytic adenoviral efficacy in human ovarian cancer cells.
Connell CM; Shibata A; Tookman LA; Archibald KM; Flak MB; Pirlo KJ; Lockley M; Wheatley SP; McNeish IA
J Clin Invest; 2011 Apr; 121(4):1283-97. PubMed ID: 21383502
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells.
Watanabe T; Hioki M; Fujiwara T; Nishizaki M; Kagawa S; Taki M; Kishimoto H; Endo Y; Urata Y; Tanaka N; Fujiwara T
Exp Cell Res; 2006 Feb; 312(3):256-65. PubMed ID: 16356494
[TBL] [Abstract][Full Text] [Related]
15. [The State of The Jak/Stat Pathway Affects the Sensitivity of TumorCells to Oncolytic Enteroviruses].
Le TH; Lipatova AV; Volskaya MA; Tikhonova OA; Chumakov PM
Mol Biol (Mosk); 2020; 54(4):634-642. PubMed ID: 32799226
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological modulation of autophagy enhances Newcastle disease virus-mediated oncolysis in drug-resistant lung cancer cells.
Jiang K; Li Y; Zhu Q; Xu J; Wang Y; Deng W; Liu Q; Zhang G; Meng S
BMC Cancer; 2014 Jul; 14():551. PubMed ID: 25078870
[TBL] [Abstract][Full Text] [Related]
17. Trail armed oncolytic poxvirus suppresses lung cancer cell by inducing apoptosis.
Hu J; Wang H; Gu J; Liu X; Zhou X
Acta Biochim Biophys Sin (Shanghai); 2018 Oct; 50(10):1018-1027. PubMed ID: 30137199
[TBL] [Abstract][Full Text] [Related]
18. DNA-PK inhibition synergizes with oncolytic virus M1 by inhibiting antiviral response and potentiating DNA damage.
Xiao X; Liang J; Huang C; Li K; Xing F; Zhu W; Lin Z; Xu W; Wu G; Zhang J; Lin X; Tan Y; Cai J; Hu J; Chen X; Huang Y; Qin Z; Qiu P; Su X; Chen L; Lin Y; Zhang H; Yan G
Nat Commun; 2018 Oct; 9(1):4342. PubMed ID: 30337542
[TBL] [Abstract][Full Text] [Related]
19. Mitophagy promotes replication of oncolytic Newcastle disease virus by blocking intrinsic apoptosis in lung cancer cells.
Meng G; Xia M; Wang D; Chen A; Wang Y; Wang H; Yu D; Wei J
Oncotarget; 2014 Aug; 5(15):6365-74. PubMed ID: 25051374
[TBL] [Abstract][Full Text] [Related]
20. Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity.
Su BH; Shieh GS; Tseng YL; Shiau AL; Wu CL
Oncotarget; 2015 Nov; 6(35):38308-26. PubMed ID: 26515462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
